Cortechs.ai | LesionQuant for assessment of MRI in MS
Cortechs.ai | LesionQuant for assessment of MRI in MS
RSNA 2025
Contact

LesionQuant for assessment of MRI in MS

  • Category: Published research
  • Product: NeuroQuant MS
  • Disease: Multiple sclerosis

LesionQuant for assessment of MRI in MS —a promising supplement to the visual scan inspection

Quantitative measurements of lesion volume, lesion count, distribution of lesions, and brain atrophy have a potentially significant value for evaluating disease progression. We hypothesize that utilizing software designed for evaluating MRI data in MS will provide more accurate and detailed analyses compared to the visual neuro-radiological evaluation. 2020.

[button]Download[/button]

  • Topic: Published research

More Resources

Cortechs Cares: Community Impact and Volunteer Efforts in 2025
  • 2 mins

03/13/2026

Cortechs Cares: Community Impact and Volunteer Efforts in 2025

Cortechs Cares highlights how our team gave back in 2025 through community volunteer efforts, including an Alzheimer’s Walk and holiday toy drive.

Cortechs.ai | LesionQuant for assessment of MRI in MS
  • 2 mins

03/11/2026

OnQ™ Prostate: Bringing Quantitative MRI to Prostate Imaging

Advancing prostate MRI with quantitative diffusion biomarkers. OnQ™ Prostate brings objective RSI-based insights to support data-driven cancer evaluation.

Cortechs.ai | LesionQuant for assessment of MRI in MS
  • 2 mins

03/04/2026

Cortechs.ai and Siemens Healthineers Partner to Expand Global Access to NeuroQuant® Technologies

NeuroQuant® Lesion Surveillance will be integrated into the Siemens Healthineers Digital Marketplace to advance quantitative brain imaging worldwide.

, ,

Cortechs.ai | LesionQuant for assessment of MRI in MS
  • 2 mins

02/25/2026

Cortechs.ai Announces MFDS (KFDA) Approval of Global-Leading NeuroQuant® V5 Platform in South Korea

MFDS approves NeuroQuant® V5 in South Korea, expanding AI-driven volumetric neuroimaging and clinical decision support.

, ,

Cortechs.ai | LesionQuant for assessment of MRI in MS
  • < 1 mins

02/24/2026

Financial Conflict Of Interest Policy Applicable To NIH Awards

Cortechs.ai | LesionQuant for assessment of MRI in MS
  • 2 mins

02/20/2026

NeuroQuant® PET: FDA 510(k)-Pending Advancement in Molecular Dementia Imaging

FDA 510(k)-Pending NeuroQuant® PET delivers automated, standardized quantification for amyloid, tau, and FDG imaging in dementia care.

,

View our insights
Cortechs.ai | LesionQuant for assessment of MRI in MS
Cortechs.ai | LesionQuant for assessment of MRI in MS

Empowering precision

and clarity in patient care

727 Madison Ave, Suite 29, Covington, Kentucky 41011

Headquarters:

5060 Shoreham Place,
Ste 240, San Diego, CA 92122

Cortechs.ai | LesionQuant for assessment of MRI in MS
Cortechs.ai | LesionQuant for assessment of MRI in MS
  • Solutions
  • © Cortechs.ai 2024
Scroll to Top